UPDATE 1-J&J revenue misses on lower-than-expected pharmaceutical sales

UPDATE 1-J&J revenue misses on lower-than-expected pharmaceutical sales


The logo of healthcare company Johnson & Johnson is seen in front of an office building in Zug, Switzerland July 20, 2016. Johnson & Johnson reported on Tuesday quarterly revenue that missed estimates due to slowing pharmaceutical sales, but the company, which is in the process of closing its $30 billion acquisition of Actelion, raised its 2017 forecast.



from Biotech News